We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Samsung Electronics Company Ltd (PK) | USOTC:SSNHZ | OTCMarkets | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1,679.75 | 1,200.00 | 1,613.65 | 0.00 | 05:01:44 |
From Apr 2019 to Apr 2024
The Samsung-developed drug will be marketed to healthcare providers by Merck & Co.'s U.S. sales team and will be sold for about a 35% discount off of Remicade's current list price. "Samsung Releases Lower-Cost Alternative to Johnson & Johnson's Drug Remicade ," at 8:21 a.m. ET, incorrectly stated that the drug will be sold for about 35% of Remicade's price. in the second paragraph.
(END) Dow Jones Newswires
July 24, 2017 09:15 ET (13:15 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
1 Year Samsung Electronics (PK) Chart |
1 Month Samsung Electronics (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
